The protective effect of heparin in experimental bladder infection.
D000327:Adsorption; D000818:Animals; D001419:Bacteria / Q000187:drug effects; D004927:Escherichia coli Infections / Q000517:prevention & control; D006025:Glycosaminoglycans / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology / Q000627:therapeutic use*; D006851:Hydrochloric Acid / Q000009:adverse effects; D008297:Male; D011817:Rabbits; D001743:Urinary Bladder / Q000187:drug effects / Q000473:pathology; D001745:Urinary Bladder Diseases / Q000517:prevention & control*; D014552:Urinary Tract Infections / Q000517:prevention & control*
D006025:Glycosaminoglycans; D006493:Heparin; D006851:Hydrochloric Acid